BOT 0.00% 36.0¢ botanix pharmaceuticals ltd

New Hartley Analyst report on Bot, page-90

  1. 1,707 Posts.
    lightbulb Created with Sketch. 94
    That would be good if management did provide a update
    following the FDA review but if they stuffed it up again why would they. Just hope next time they have it right
    then if they get it right then no more rubbish talk and everyone
    makes truckloads of money he’s hoping
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.